Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition. [electronic resource]
- Nature communications 10 2018
- 4508 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2041-1723
10.1038/s41467-018-06823-9 doi
Allosteric Regulation--genetics Humans Mutation Oncogene Proteins Piperidines--metabolism Protein Conformation Protein Tyrosine Phosphatase, Non-Receptor Type 11--antagonists & inhibitors Pyrimidines--metabolism